| Carcinoma–astrocyte gap junctions promote brain metastasis by cGAMP transfer Q Chen, A Boire, X Jin, M Valiente, EE Er, A Lopez-Soto, L S. Jacob, ... Nature 533 (7604), 493-498, 2016 | 807 | 2016 |
| Control of metastasis by NK cells A López-Soto, S Gonzalez, MJ Smyth, L Galluzzi Cancer cell 32 (2), 135-154, 2017 | 629 | 2017 |
| The hallmarks of successful anticancer immunotherapy L Galluzzi, TA Chan, G Kroemer, JD Wolchok, A López-Soto Science translational medicine 10 (459), eaat7807, 2018 | 483 | 2018 |
| Caspases connect cell-death signaling to organismal homeostasis L Galluzzi, A López-Soto, S Kumar, G Kroemer Immunity 44 (2), 221-231, 2016 | 367 | 2016 |
| NKG2D ligands: key targets of the immune response S González, A López-Soto, B Suarez-Alvarez, A López-Vázquez, ... Trends in immunology 29 (8), 397-403, 2008 | 299 | 2008 |
| WNT signaling in cancer immunosurveillance L Galluzzi, S Spranger, E Fuchs, A López-Soto Trends in cell biology 29 (1), 44-65, 2019 | 195 | 2019 |
| NKG2D signaling in cancer immunosurveillance A López‐Soto, L Huergo‐Zapico, A Acebes‐Huerta, M Villa‐Alvarez, ... International journal of cancer 136 (8), 1741-1750, 2015 | 151 | 2015 |
| The NKG2D receptor: sensing stressed cells C López-Larrea, B Suárez-Alvarez, A López-Soto, A López-Vázquez, ... Trends in molecular medicine 14 (4), 179-189, 2008 | 148 | 2008 |
| HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer A López-Soto, AR Folgueras, E Seto, S Gonzalez Oncogene 28 (25), 2370-2382, 2009 | 130 | 2009 |
| Epithelial–mesenchymal transition induces an antitumor immune response mediated by NKG2D receptor A López-Soto, L Huergo-Zapico, JA Galván, L Rodrigo, AG de Herreros, ... The Journal of Immunology 190 (8), 4408-4419, 2013 | 114 | 2013 |
| Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia AP Gonzalez-Rodriguez, J Contesti, L Huergo-Zapico, A Lopez-Soto, ... Leukemia & lymphoma 51 (10), 1829-1836, 2010 | 108 | 2010 |
| Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease L Huergo-Zapico, A Acebes-Huerta, AP Gonzalez-Rodriguez, J Contesti, ... PloS one 9 (10), e108326, 2014 | 103 | 2014 |
| NK cell-based immunotherapy in cancer metastasis S Lorenzo-Herrero, A López-Soto, C Sordo-Bahamonde, ... Cancers 11 (1), 29, 2018 | 101 | 2018 |
| Lenalidomide induces immunomodulation in chronic lymphocytic leukemia and enhances antitumor immune responses mediated by NK and CD4 T cells A Acebes-Huerta, L Huergo-Zapico, AP Gonzalez-Rodriguez, ... BioMed research international 2014, 2014 | 80 | 2014 |
| Mechanisms of apoptosis resistance to NK cell-mediated cytotoxicity in cancer C Sordo-Bahamonde, S Lorenzo-Herrero, ÁR Payer, S Gonzalez, ... International journal of molecular sciences 21 (10), 3726, 2020 | 78 | 2020 |
| Molecular bases for the regulation of NKG2D ligands in cancer L Huergo-Zapico, A Acebes-Huerta, A López-Soto, M Villa-Álvarez, ... Frontiers in immunology 5, 106, 2014 | 74 | 2014 |
| Transcriptional regulation of ULBP1, a human ligand of the NKG2D receptor A López-Soto, A Quiñones-Lombraña, R López-Arbesú, C López-Larrea, ... Journal of biological chemistry 281 (41), 30419-30430, 2006 | 73 | 2006 |
| Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding L Huergo-Zapico, AP Gonzalez-Rodriguez, J Contesti, E Gonzalez, ... Cancer Immunology, Immunotherapy 61, 1201-1210, 2012 | 70 | 2012 |
| Conceptual aspects of self and nonself discrimination S Gonzalez, AP González-Rodríguez, A López-Soto, L Huergo-Zapico, ... Self/nonself 2 (1), 19-25, 2011 | 70 | 2011 |
| CD107a degranulation assay to evaluate immune cell antitumor activity S Lorenzo-Herrero, C Sordo-Bahamonde, S Gonzalez, A López-Soto Cancer Immunosurveillance: Methods and Protocols, 119-130, 2019 | 69 | 2019 |
